Compare Fox Corp Class B (FOX) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class B vs TransMedics Group Inc — how do they compare? Fox Corp Class B trades at $55.42 (market cap $24.58B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Fox Corp Class B is far larger — about 7.9× TransMedics Group Inc's market cap, and Fox Corp Class B pays a 1.05% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| FOX | TMDX | |
|---|---|---|
Market Cap | $24.58B | $3.10B |
Sector | Media | Technology |
52-Week High | $67.76 | $150.42 |
52-Week Low | $44.39 | $61.99 |
Enterprise Value | $27.94B | $3.49B |
Dividend Yield | 1.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fox Corp Class B
Fox represents the assets not sold to Disney by the predecessor firm, Twenty First Century Fox. The remaining assets include Fox News, the FOX broadcast network, FS1 and FS2, Fox Business, Big Ten Network, 28 owned and operated local television stations of which 17 are affiliated with the Fox Network, and the Fox Studios lot. The Murdoch family continues to control the successor firm, which represents a large-scale bet on the value of live sports and news in the U.S. market.
Read more on FOX →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
